(Q37635097)

21 August 2017

1 reference

title

Early detection of breast cancer: new biomarker tests on the horizon? (English)

1 reference

21 August 2017

0 references

Aparna C Jotwani

1

1 reference

21 August 2017

Julie R Gralow

series ordinal

2

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Molecular Diagnosis and Therapy

21 August 2017

published in

1 reference

21 August 2017

volume

13

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

349-357

1 reference

The case for early detection

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Biomarkers for early detection of breast cancer: what, when, and where?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Proteomics of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

A mouse model repository for cancer biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

The human plasma proteome: history, character, and diagnostic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Is the small heat shock protein alphaB-crystallin an oncogene?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

CEA and HMFG in hyperplastic and malignant lesions of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

MUC1 and the immunobiology of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

The molecular etiology of breast cancer: evidence from biomarkers of risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Breast-tissue sampling for risk assessment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Breast cancer incidence in women with abnormal cytology in nipple aspirates of breast fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Breast cancer risk in women with abnormal cytology in nipple aspirates of breast fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Nipple aspirate fluid cytology and the Gail model for breast cancer risk assessment in a screening population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Epithelial cells in nipple aspirate fluid and subsequent breast cancer risk: a historic prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Technical enhancements to breast ductal lavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

C-reactive protein in nipple aspirate fluid associated with Gail model factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Analysis of the presence of cutaneous and mucosal papillomavirus types in ductal lavage fluid, milk and colostrum to evaluate its role in breast carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

The possible involvement of virus in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

MUC1 (EMA) : une molécule clé de la carcinogenèse ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256340

Molecular analysis of nipple fluid for breast cancer screening.

21 January 2018

1 reference

12 December 2020

Cytologic evaluation of breast fluid in the detection of breast disease

1 reference

12 December 2020

Screening for breast cancer with mammography

1 reference

12 December 2020

Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studies

1 reference

12 December 2020

Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization.

1 reference

12 December 2020

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

1 reference

12 December 2020

Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

MUC1 (EMA): A key molecule of carcinogenesis?

1 reference

12 December 2020

Glycoprotein changes in tumours: a renaissance in clinical applications

1 reference

12 December 2020

Involvement of annexin II in DNA replication: evidence from cell-free extracts of Xenopus eggs.

1 reference

12 December 2020

Breast cancer: new technologies for risk assessment and diagnosis

1 reference

12 December 2020

Serum (circulating) tumor markers for breast cancer.

1 reference

12 December 2020

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256340

1 reference

21 August 2017

1 reference